Significantly, GM-CSF can easily cross the blood-brain barrier82, and our work with GM-CSF in both animals and humans indicates that it can ameliorate CNS disorders of various kinds that include an inflammatory component. The gene discussed is CSF2; the disease is central nervous system disorder.